Peter Pyrko

1.0k total citations
8 papers, 836 citations indexed

About

Peter Pyrko is a scholar working on Physiology, Cell Biology and Pharmacology. According to data from OpenAlex, Peter Pyrko has authored 8 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 4 papers in Cell Biology and 3 papers in Pharmacology. Recurrent topics in Peter Pyrko's work include Adenosine and Purinergic Signaling (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Autophagy in Disease and Therapy (3 papers). Peter Pyrko is often cited by papers focused on Adenosine and Purinergic Signaling (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Autophagy in Disease and Therapy (3 papers). Peter Pyrko collaborates with scholars based in United States and Russia. Peter Pyrko's co-authors include Axel H. Schönthal, Thomas C. Chen, Florence M. Hofman, Amy S. Lee, Adel Kardosh, Nicos A. Petasis, Jasim Uddin, Wenyong Xiong, Stan G. Louie and Weijun Wang and has published in prestigious journals such as Cancer Research, Journal of neurosurgery and Biochemical Pharmacology.

In The Last Decade

Peter Pyrko

8 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Pyrko United States 8 445 399 309 103 86 8 836
Pamela Hale United States 13 438 1.0× 500 1.3× 403 1.3× 95 0.9× 176 2.0× 17 1.2k
Mitchell Vamos United States 8 131 0.3× 494 1.2× 514 1.7× 71 0.7× 65 0.8× 11 891
Michael Ewing United States 9 241 0.5× 253 0.6× 309 1.0× 76 0.7× 100 1.2× 13 664
Zhineng J. Yang United States 6 142 0.3× 758 1.9× 795 2.6× 114 1.1× 142 1.7× 9 1.2k
Nur Mehpare Kocatürk Türkiye 7 132 0.3× 409 1.0× 356 1.2× 39 0.4× 67 0.8× 11 708
Sulochanadevi Baskaran United States 11 256 0.6× 292 0.7× 356 1.2× 26 0.3× 17 0.2× 12 664
Brent E. Fitzwalter United States 9 120 0.3× 631 1.6× 615 2.0× 70 0.7× 71 0.8× 10 963
Marc Germain Canada 8 153 0.3× 713 1.8× 283 0.9× 39 0.4× 284 3.3× 8 1.0k
Rachel Kama Israel 12 320 0.7× 676 1.7× 161 0.5× 11 0.1× 93 1.1× 13 911
Caisheng Lu United States 9 98 0.2× 383 1.0× 398 1.3× 49 0.5× 71 0.8× 13 656

Countries citing papers authored by Peter Pyrko

Since Specialization
Citations

This map shows the geographic impact of Peter Pyrko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Pyrko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Pyrko more than expected).

Fields of papers citing papers by Peter Pyrko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Pyrko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Pyrko. The network helps show where Peter Pyrko may publish in the future.

Co-authorship network of co-authors of Peter Pyrko

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Pyrko. A scholar is included among the top collaborators of Peter Pyrko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Pyrko. Peter Pyrko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kardosh, Adel, Encouse B. Golden, Peter Pyrko, et al.. (2008). Aggravated Endoplasmic Reticulum Stress as a Basis for Enhanced Glioblastoma Cell Killing by Bortezomib in Combination with Celecoxib or Its Non-Coxib Analogue, 2,5-Dimethyl-Celecoxib. Cancer Research. 68(3). 843–851. 113 indexed citations
2.
Kardosh, Adel, Peter Pyrko, Yen‐Ting Liu, et al.. (2007). Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib. Journal of Biomedical Science. 14(5). 647–662. 14 indexed citations
3.
Pyrko, Peter, Adel Kardosh, & Axel H. Schönthal. (2007). Celecoxib transiently inhibits cellular protein synthesis. Biochemical Pharmacology. 75(2). 395–404. 26 indexed citations
4.
Pyrko, Peter, Adel Kardosh, Yen‐Ting Liu, et al.. (2007). Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib. Molecular Cancer Therapeutics. 6(4). 1262–1275. 111 indexed citations
5.
Pyrko, Peter, Adel Kardosh, Weijun Wang, et al.. (2007). HIV-1 Protease Inhibitors Nelfinavir and Atazanavir Induce Malignant Glioma Death by Triggering Endoplasmic Reticulum Stress. Cancer Research. 67(22). 10920–10928. 110 indexed citations
6.
Pyrko, Peter, Axel H. Schönthal, Florence M. Hofman, Thomas C. Chen, & Amy S. Lee. (2007). The Unfolded Protein Response Regulator GRP78/BiP as a Novel Target for Increasing Chemosensitivity in Malignant Gliomas. Cancer Research. 67(20). 9809–9816. 377 indexed citations
8.
Pyrko, Peter, Weijun Wang, Francis S. Markland, et al.. (2005). The role of contortrostatin, a snake venom disintegrin, in the inhibition of tumor progression and prolongation of survival in a rodent glioma model. Journal of neurosurgery. 103(3). 526–537. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026